(Q67486058)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310878%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

Factor IXi-antithrombin (IXiAT) and thrombin-antithrombin (TAT) complexes in lung cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310878%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

author name string

B. Kemkes-Matthes

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310878

11 September 2022

H. Bleyl

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310878

11 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1310878

11 September 2022

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310878%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

14 September 2019

http://link.springer.com/content/pdf/10.1007/BF01811469.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01811469/fulltext.html

1 December 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF01811469

1 December 2023

1 reference

1 December 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310878%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310878%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310878%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

35-39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310878%20AND%20SRC:MED&resulttype=core&format=json

Antimetastatic agents. I. Role of cellular procoagulants in the pathogenesis of fibrin deposition in cancer and the use of anticoagulants and/or antiplatelet drugs in cancer treatment

14 September 2019

cites work

1 reference

12 December 2020

Protein C antigen is not an acute phase reactant and is often high in ischemic heart disease and diabetes

1 reference

12 December 2020

Thrombosis and cancer

1 reference

12 December 2020

Elevated thrombin-antithrombin III complex concentrations in patients with gynaecological malignancy

1 reference

12 December 2020

Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases

1 reference

12 December 2020

Significance of plasma fibrinopeptide A (fpA) in patients with malignancy

1 reference

12 December 2020

A factor X-activating cysteine protease from malignant tissue

1 reference

12 December 2020

Hemostatic Abnormalities in Malignancy, a Prospective Study of One Hundred Eight Patients: Part I. Coagulation Studies

1 reference

12 December 2020

Assessment of hypercoagulable states by measurement of activation fragments and peptides

1 reference

12 December 2020

Analysis of serum cancer procoagulant activity and its possible use as a tumor marker

1 reference

12 December 2020

Pathophysiologic and biochemical events in disseminated intravascular coagulation: dysregulation of procoagulant and anticoagulant pathways

1 reference

12 December 2020

Activation of blood coagulation in cancer: Trousseau's syndrome revisited.

1 reference

12 December 2020

Immunological and functional determination of the protease inhibitors, protein C and antithrombin III, in liver cirrhosis and in neoplasia

1 reference

12 December 2020

Low prevalence of coagulation and fibrinolytic activation in patients with primary untreated cancer

1 reference

12 December 2020

Comparison of procoagulant activity in tissue culture medium from normal and transformed fibroblasts

1 reference

12 December 2020

Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation

1 reference

12 December 2020

Indices of hypercoagulation in cancer as compared with those in acute inflammation and acute infarction

1 reference

12 December 2020

Causes of death in cancer patients.

1 reference

12 December 2020

[Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer]

1 reference

12 December 2020

Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease

1 reference

12 December 2020

Clotting activation and impairment of fibrinolysis in malignancy

1 reference

12 December 2020

Cancer procoagulant A: A factor X activating procoagulant from malignant tissue

1 reference

12 December 2020

Studies on the pathogenesis of coagulopathy in patients with arterial thromboembolism and malignancy

1 reference

12 December 2020

Thrombin generation in acute promyelocytic leukemia

1 reference

12 December 2020

A proteolytic procoagulant associated with malignant transformation.

1 reference

12 December 2020

Coagulation disorders in cancer.I. Clinical and laboratory studies

1 reference

12 December 2020

Cysteine proteinase procoagulant from amnion-chorion

1 reference

12 December 2020

Evidence that cells from experimental tumours can activate coagulation factor X.

1 reference

12 December 2020

Comparison of procoagulant activities in extracts of normal and malignant human tissue

1 reference

12 December 2020

Coagulation abnormalities in patients with inoperable lung cancer

1 reference

12 December 2020

Abnormalities of blood coagulation tests in patients with cancer

1 reference

12 December 2020

Abnormalities of blood coagulation in patients with cancer. Fibrinopeptide A generation and tumor growth

1 reference

12 December 2020

Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.

1 reference

12 December 2020

3

41

927

H Bleyl

1990

1 reference

Journal of the National Cancer Institute

1 December 2023

15

62

773

SG Gordon

1979

1 reference

1 December 2023

17

49

649

AB Hagedorn

1974

1 reference

The American journal of cancer

1 December 2023

29

34

566

EE Sproulw

1983

1 reference

1 December 2023

Identifiers

DOI

10.1007/BF01811469

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1310878%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference